Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 904

1.

Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.

Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L.

Cancer Res. 2002 Mar 15;62(6):1884-9.

2.

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

PMID:
15146294
3.
4.
6.

Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.

Okada H, Tsugawa T, Sato H, Kuwashima N, Gambotto A, Okada K, Dusak JE, Fellows-Mayle WK, Papworth GD, Watkins SC, Chambers WH, Potter DM, Storkus WJ, Pollack IF.

Cancer Res. 2004 Aug 15;64(16):5830-8.

7.

Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy.

Shimizu K, Kuriyama H, Kjaergaard J, Lee W, Tanaka H, Shu S.

J Immunother. 2004 Jul-Aug;27(4):265-72.

PMID:
15235387
8.

Targeting apoptotic tumor cells to Fc gamma R provides efficient and versatile vaccination against tumors by dendritic cells.

Akiyama K, Ebihara S, Yada A, Matsumura K, Aiba S, Nukiwa T, Takai T.

J Immunol. 2003 Feb 15;170(4):1641-8.

9.
10.

Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor.

Hornung RL, Longo DL, Bowersox OC, Kwak LW.

J Natl Cancer Inst. 1995 Sep 6;87(17):1289-96.

PMID:
7544833
11.

The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.

Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.

Int J Oncol. 2006 Apr;28(4):947-53.

PMID:
16525645
12.

Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.

De Veerman M, Heirman C, Van Meirvenne S, Devos S, Corthals J, Moser M, Thielemans K.

J Immunol. 1999 Jan 1;162(1):144-51.

13.

Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity.

Kim KW, Kim SH, Jang JH, Lee EY, Park SW, Um JH, Lee YJ, Lee CH, Yoon S, Seo SY, Jeong MH, Lee ST, Chung BS, Kang CD.

Cancer Immunol Immunother. 2004 Apr;53(4):315-22. Epub 2003 Dec 18.

PMID:
14685778
14.

Enhancement of antigen-presenting capacity and antitumor immunity of dendritic cells pulsed with autologous tumor-derived RNA in mice.

Minami T, Nakanishi Y, Izumi M, Harada T, Hara N.

J Immunother. 2003 Sep-Oct;26(5):420-31.

PMID:
12973031
15.

Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells.

Wan Y, Emtage P, Zhu Q, Foley R, Pilon A, Roberts B, Gauldie J.

Cell Immunol. 1999 Dec 15;198(2):131-8.

PMID:
10648127
16.

Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.

Schnurr M, Scholz C, Rothenfusser S, Galambos P, Dauer M, Röbe J, Endres S, Eigler A.

Cancer Res. 2002 Apr 15;62(8):2347-52.

18.

Induction of antitumor immunity using bone marrow-generated dendritic cells.

Porgador A, Snyder D, Gilboa E.

J Immunol. 1996 Apr 15;156(8):2918-26.

PMID:
8609412
19.

HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.

Yin R, Zheng W, Hao F, Yang XC, Zhong BY, Li QJ.

J Dermatol Sci. 2009 Aug;55(2):116-22. doi: 10.1016/j.jdermsci.2009.04.008. Epub 2009 Jun 4.

PMID:
19500947
20.

Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.

Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, Wainstok R.

J Immunol. 2003 Dec 1;171(11):5940-7.

Supplemental Content

Support Center